Overview
Osmotic demyelination syndrome (ODS), also known as central pontine myelinolysis (CPM), involves the destruction of myelin sheaths in the central nervous system, often triggered by rapid shifts in serum osmolality, particularly in predisposed individuals 1.Diagnosis
Clinical presentation includes altered mental status, pseudobulbar palsies, and limb weakness 1.
Neuroimaging (MRI) shows characteristic changes in the brainstem and spinal cord 1.
Electrolyte panel essential to identify rapid changes in sodium levels, though ODS can occur without preceding hyponatremia 1.Management
Control serum osmolality: Gradual correction of sodium levels to avoid further brain injury 1.
Supportive care: Management of symptoms including respiratory support, physical therapy, and monitoring for complications 1.
Address underlying conditions: Treatment of predisposing factors such as alcoholism, liver disease, or adrenal insufficiency 1.Special Populations
Pregnancy/Postpartum state: Increased susceptibility noted; careful management of fluid and electrolyte balance required 1.
Comorbidities: Conditions like liver disease, malnutrition, and severe illness elevate risk; vigilant monitoring and cautious fluid management advised 1.Key Recommendations
Avoid rapid fluctuations in serum sodium concentrations, even in the absence of hyponatremia, particularly in individuals with predisposing factors such as alcoholism, liver disease, or malnutrition (Evidence: Moderate 1).
Vigilantly monitor and manage predisposing conditions (e.g., adrenal insufficiency, severe illness) to prevent ODS (Evidence: Moderate 1).
Gradually correct hypernatremia to minimize risk of osmotic demyelination in susceptible patients (Evidence: Moderate 1).References
1 Shah MK, Mandayam S, Adrogué HJ. Osmotic Demyelination Unrelated to Hyponatremia. American journal of kidney diseases : the official journal of the National Kidney Foundation 2018. link